Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
27.70
+0.70 (2.59%)
Nov 22, 2024, 4:00 PM EST - Market closed
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $1.63 billion as of November 22, 2024. Its market cap has increased by 3,655.57% in one year.
Market Cap
1.63B
Enterprise Value
1.37B
1-Year Change
3,655.57%
Ranking
Category
Stock Price
$27.70
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $1.63B, an increase of 1,355.83%. That is a compound annual growth rate of 36.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.38B | 1,488.40% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 10x Genomics | 1.73B |
| Clover Health Investments | 1.69B |
| Certara | 1.67B |
| Recursion Pharmaceuticals | 1.63B |
| Dynavax Technologies | 1.63B |
| Immunocore Holdings | 1.62B |
| InMode | 1.61B |
| Viridian Therapeutics | 1.60B |